Last Updated: February 7, 2018
25 mg, bottle, 100 count (NDC 00591-5713-01)
50 mg, bottle, 100 count (NDC 00591-5714-01)
100 mg, bottle, 100 count (NDC 00591-5715-01)
150 mg, bottle, 30 count (NDC 00591-5716-30)
- Teva did not provide a reason for the shortage.
- Teva is the sole supplier of amoxapine.
There are no presentations available
Estimated Resupply Dates
Teva has amoxapine tablets on back order and the company estimates a release date in early-March 2018.
February 7, 2018; December 15, 2017, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.